SE1069132T5 - Bicykliska derivate av amino-pyrazinoner, foerfarande foer framstaellning och farmaceutiska kompositioner innehallande dem - Google Patents

Bicykliska derivate av amino-pyrazinoner, foerfarande foer framstaellning och farmaceutiska kompositioner innehallande dem

Info

Publication number
SE1069132T5
SE1069132T5 SE00401686T SE00401686T SE1069132T5 SE 1069132 T5 SE1069132 T5 SE 1069132T5 SE 00401686 T SE00401686 T SE 00401686T SE 00401686 T SE00401686 T SE 00401686T SE 1069132 T5 SE1069132 T5 SE 1069132T5
Authority
SE
Sweden
Prior art keywords
pyrazinones
amino
processes
preparation
pharmaceutical compositions
Prior art date
Application number
SE00401686T
Other languages
English (en)
Swedish (sv)
Other versions
SE1069132T3 (sv
Inventor
Nanteuil Guillaume De
Philippe Gloanec
Tony Verbeuren
Alain Rupin
Marie-Odile Vallez
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of SE1069132T3 publication Critical patent/SE1069132T3/xx
Publication of SE1069132T5 publication Critical patent/SE1069132T5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE00401686T 1999-06-15 2000-06-15 Bicykliska derivate av amino-pyrazinoner, foerfarande foer framstaellning och farmaceutiska kompositioner innehallande dem SE1069132T5 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9907538A FR2795072B1 (fr) 1999-06-15 1999-06-15 Nouveaux derives bicycliques d'amino-pyrazinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
SE1069132T3 SE1069132T3 (sv) 2003-12-09
SE1069132T5 true SE1069132T5 (sv) 2004-01-07

Family

ID=9546789

Family Applications (1)

Application Number Title Priority Date Filing Date
SE00401686T SE1069132T5 (sv) 1999-06-15 2000-06-15 Bicykliska derivate av amino-pyrazinoner, foerfarande foer framstaellning och farmaceutiska kompositioner innehallande dem

Country Status (23)

Country Link
US (1) US6277851B1 (pl)
EP (1) EP1069132B1 (pl)
JP (1) JP3364472B2 (pl)
KR (1) KR100456796B1 (pl)
CN (1) CN1147489C (pl)
AT (1) ATE251177T1 (pl)
AU (1) AU766194B2 (pl)
BR (1) BR0002643A (pl)
CA (1) CA2312206C (pl)
DE (1) DE60005609T2 (pl)
DK (1) DK1069132T3 (pl)
EA (1) EA003209B1 (pl)
ES (1) ES2208239T3 (pl)
FR (1) FR2795072B1 (pl)
HK (1) HK1032236A1 (pl)
HU (1) HUP0002277A3 (pl)
NO (1) NO316650B1 (pl)
NZ (1) NZ505149A (pl)
PL (1) PL199522B1 (pl)
PT (1) PT1069132E (pl)
SE (1) SE1069132T5 (pl)
SI (1) SI1069132T1 (pl)
ZA (1) ZA200003034B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001245356A1 (en) * 2000-02-29 2001-09-12 Bristol-Myers Squibb Pharma Company Inhibitors of hepatitis c virus ns3 protease
FR2818277B1 (fr) * 2000-12-14 2003-01-24 Servier Lab Nouveaux derives bicycliques d'amino-pyrazinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2003243657A1 (en) * 2002-06-26 2004-01-19 Bristol-Myers Squibb Company Amino-bicyclic pyrazinones and pyridinones
FR2867780B1 (fr) * 2004-03-19 2006-05-19 Servier Lab Nouveaux derives de 4-oxo-4,6,7,8-tetrahydropyrrolo (1,2-a) pyrazine-6-carboxamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP2807156A1 (en) * 2012-01-27 2014-12-03 Novartis AG Aminopyridine derivatives as plasma kallikrein inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05117276A (ja) * 1991-10-23 1993-05-14 Sumitomo Pharmaceut Co Ltd 新規な３環性キノキサリンジオン誘導体
SK83897A3 (en) * 1994-12-22 1998-05-06 Iaf Biochem Int Low molecular weight bicyclic thrombin inhibitors
WO1996030396A1 (en) * 1995-03-24 1996-10-03 Molecumetics Ltd. β-SHEET MIMETICS AND USE THEREOF AS PROTEASE INHIBITORS
WO1997030708A1 (en) * 1996-02-22 1997-08-28 Merck & Co., Inc. Pyridinone thrombin inhibitors
US6124291A (en) * 1996-06-18 2000-09-26 Warner-Lambert Company Pyrrolo[1,2-a]pyrazine-1,4-dione serine protease inhibitors
WO1998009987A1 (en) * 1996-09-06 1998-03-12 Biochem Pharma, Inc. Lactam inhibitors of thrombin
WO1998017274A1 (en) * 1996-10-24 1998-04-30 Merck & Co., Inc. Thrombin inhibitors
US5792779A (en) * 1997-02-19 1998-08-11 Merck & Co., Inc. Pyridinone thrombin inhibitors
CA2301614A1 (en) * 1997-09-23 1999-04-01 Merck & Co., Inc. Thrombin inhibitors

Also Published As

Publication number Publication date
EA003209B1 (ru) 2003-02-27
HU0002277D0 (en) 2000-08-28
EP1069132A1 (fr) 2001-01-17
EA200000527A2 (ru) 2000-12-25
HK1032236A1 (en) 2001-07-13
CN1277198A (zh) 2000-12-20
NO316650B1 (no) 2004-03-22
BR0002643A (pt) 2001-01-02
KR100456796B1 (ko) 2004-11-10
CN1147489C (zh) 2004-04-28
CA2312206A1 (fr) 2000-12-15
NZ505149A (en) 2001-01-26
EA200000527A3 (ru) 2001-04-23
FR2795072B1 (fr) 2001-07-27
ZA200003034B (en) 2001-01-11
EP1069132B1 (fr) 2003-10-01
AU4086500A (en) 2000-12-21
PL199522B1 (pl) 2008-09-30
DK1069132T3 (da) 2004-02-02
PT1069132E (pt) 2004-02-27
JP3364472B2 (ja) 2003-01-08
HUP0002277A3 (en) 2002-12-28
ES2208239T3 (es) 2004-06-16
PL340784A1 (en) 2000-12-18
SE1069132T3 (sv) 2003-12-09
NO20002941D0 (no) 2000-06-08
KR20010066846A (ko) 2001-07-11
NO20002941L (no) 2000-12-18
US6277851B1 (en) 2001-08-21
CA2312206C (fr) 2004-07-06
SI1069132T1 (en) 2003-12-31
DE60005609D1 (de) 2003-11-06
HUP0002277A2 (hu) 2001-05-28
JP2001026592A (ja) 2001-01-30
DE60005609T2 (de) 2004-08-05
ATE251177T1 (de) 2003-10-15
FR2795072A1 (fr) 2000-12-22
AU766194B2 (en) 2003-10-09

Similar Documents

Publication Publication Date Title
TW200612920A (en) Novel imidazolidine derivatives
BRPI0211844B8 (pt) composto de ácido fenóxi-acético ou um de seus sais farmaceuticamente aceitáveis, e, composição farmacêutica
MXPA05007496A (es) Tienopirimidindionas y su uso en la modulacion de enfermedades autoinmunes.
EA200600487A1 (ru) Соединения инданилпиперазина, способ их получения и содержащие их фармацевтические композиции
EA200000792A3 (ru) Новые пиридиновые соединения, способ их получения и содержащие их фармацевтические композиции
DK1233953T3 (da) Nye benzoethiadiazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende samme
EA200100090A2 (ru) Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции
IL148875A0 (en) Sulfonyl hydrazide derivatives, their preparation and pharmaceutical compositions containing them
SE1069132T5 (sv) Bicykliska derivate av amino-pyrazinoner, foerfarande foer framstaellning och farmaceutiska kompositioner innehallande dem
NZ514758A (en) Cyclobutenedione compounds to treat conditions in which endothelial dysfunction is known
EA200001101A1 (ru) НОВЫЕ ДИГИДРОФУРО[3,4-b]ХИНОЛИН-1-ОНЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
EA200101204A1 (ru) Новые бициклические соединения аминопиразинона, способ их получения и содержащие их фармацевтические композиции
ATE63306T1 (de) Indolderivate.
NO20026004D0 (no) Nye podofyllotoksinkarbamat- og tiokarbamatforbindelser, fremgangsmåte vedderes fremstilling og farmasöytiske sammensetninger inneholdendedem
AU2001259242A1 (en) Process for the preparation of chemical compounds
NO903512L (no) Nye 1-oxa-2-oxo-8-azaspiro(4,5)decanderivater, farmasoeytiske preparater som inneholder dem og fremgangsmaate for fremstilling av dem.
FI20022159A0 (fi) Uusia farmaseuttisia yhdisteitä
ES2193926T3 (es) Nuevos derivados (dihidro)-benzoxazinicos y (dihidro)-benzotiazinicos substituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DE69714709T2 (de) Cyclische amic-säurederivate
EA200200379A2 (ru) Новые соединения пиримидин-4-она, способ их получения и содержащие их фармацевтические композиции
FI903511A0 (fi) Pyrrolo (2,1-b) tiazolderivat.
NO20022891L (no) Nye cykliske <alfa>-amino-<gamma>-hydroksyamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetningerinneholdende dem
NO20023023D0 (no) Nye 3-imino-1,2-ditiolforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
TH76337A (th) อนุพันธ์อิมิแดโซลิดีนชนิดใหม่
TH22954A (th) อนุพันธ์เฮเทอโรไซคลิค สไปโร